CLGN

COLLPLANT BIOTECHNOLOGIES LT

CLGN·M2R51X116·US·Common Stock·Healthcare - Biotechnology-Activist

CLGN (COLLPLANT BIOTECHNOLOGIES LT) is held by 12 institutional investors as of Q1 2026. Largest holders: BROWN ADVISORY INC ($63,640), Pathstone Holdings, LLC ($30,552), CITADEL ADVISORS LLC ($17,211). Net institutional sentiment: Mixed.

12
Holders
Avg rating(4 Elite)
$129,541
Total Value
64% (13)
Fund Consensus
7 buying - 4 selling
CLGNSmart Money Verdict
View all
Held by 12 funds
4 elite
Who's Trading
ActivistASAmi Sagy12.9%Nov 28, 2025
ActivistLLLoewenbaum Lilian S.1.5%Nov 7, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
118,731$63,6400.0%-96.69%
0
Increased
57,000(+235.3%)$30,5520.0%-72.41%
32
New
32,165$17,2110.0%-35.09%
28
Decreased
16,800(-4.5%)$9,0050.0%-80.90%
0
Increased
14,795(+2.9%)$7,9170.0%-73.13%
17
Decreased
1,400(-71.4%)$7490.0%-88.03%
0
Increased
345(+3.0%)$1840.0%-89.72%
8
Decreased
300(-85.0%)$1610.0%-89.74%
0
New
118$630.0%-35.09%
17
New
95$510.0%-35.09%
17
Increased
12,600(+6.7%)$70.0%-72.55%
12
Unchanged
1$10.0%-88.03%
0
Exited
0(-100.0%)$3,5000.0%-84.30%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used